Emergent Radiotherapy for Leukemia-Induced Cranial Neuropathies Refractory to Intrathecal Therapy
- PMID: 34178531
- PMCID: PMC8221003
- DOI: 10.7759/cureus.15212
Emergent Radiotherapy for Leukemia-Induced Cranial Neuropathies Refractory to Intrathecal Therapy
Abstract
Neurologic symptoms from leukemic infiltration of the central nervous system are an oncologic emergency, and expeditious treatment is required to preserve function. We report the case of a 44-year-old patient with relapsed acute myeloid leukemia (AML) who developed sub-acute cranial neuropathies refractory to treatment with intrathecal (IT) chemotherapy. The patient was therefore treated with an emergent course of whole-brain radiotherapy, resulting in immediate improvement and subsequent resolution of cranial neuropathies. This case illustrates that while central nervous system involvement by AML is rare, radiotherapy remains an effective modality to avoid long-term morbidity in patients failing to respond to systemic or IT chemotherapy.
Keywords: acute myeloid leukemia (aml); cns manifestations; palliative radiation therapy; rare eye disorders; whole brain radiation.
Copyright © 2021, Patel et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures



Similar articles
-
Acute Myeloid Leukemia Relapse Presenting as Complete Monocular Vision Loss due to Optic Nerve Involvement.Case Rep Hematol. 2016;2016:3794284. doi: 10.1155/2016/3794284. Epub 2016 Sep 7. Case Rep Hematol. 2016. PMID: 27668104 Free PMC article.
-
The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement.Haematologica. 1997 Sep-Oct;82(5):577-80. Haematologica. 1997. PMID: 9407724 Clinical Trial.
-
Clinical outcome and efficacy of current anti-leukemic therapy for leptomeningeal involvement in acute myeloid leukemia.Int J Hematol. 2016 Nov;104(5):574-581. doi: 10.1007/s12185-016-2063-6. Epub 2016 Jul 18. Int J Hematol. 2016. PMID: 27431487
-
Leptomeningeal involvement in chronic lymphocytic leukemia.Cancer Pract. 1998 Jul-Aug;6(4):223-8. doi: 10.1046/j.1523-5394.1998.006004223.x. Cancer Pract. 1998. PMID: 9767335 Review.
-
A narrative review of central nervous system involvement in acute leukemias.Ann Transl Med. 2021 Jan;9(1):68. doi: 10.21037/atm-20-3140. Ann Transl Med. 2021. PMID: 33553361 Free PMC article. Review.
Cited by
-
Central Nervous System Involvement in Adults with Acute Leukemia: Diagnosis, Prevention, and Management.Curr Oncol Rep. 2022 Apr;24(4):427-436. doi: 10.1007/s11912-022-01220-4. Epub 2022 Feb 10. Curr Oncol Rep. 2022. PMID: 35141858 Review.
-
Central Nervous System Prophylaxis and Treatment in Acute Leukemias.Curr Treat Options Oncol. 2022 Dec;23(12):1829-1844. doi: 10.1007/s11864-022-01032-5. Epub 2022 Dec 13. Curr Treat Options Oncol. 2022. PMID: 36510037 Free PMC article. Review.
-
Early Ophthalmological Manifestations of Acute Myeloid Leukemia: Current Perspectives.Clin Ophthalmol. 2022 Jul 1;16:2119-2127. doi: 10.2147/OPTH.S342720. eCollection 2022. Clin Ophthalmol. 2022. PMID: 35800672 Free PMC article. Review.
References
-
- Cranial nerve involvement in children with leukemia and lymphoma. Paryani SB, Donaldson SS, Amylon MD, Link MP. J Clin Oncol. 1983;1:542–545. - PubMed
-
- Cytogenetic profile of patients with acute myeloid leukemia and central nervous system disease. Shihadeh F, Reed V, Faderl S, et al. Cancer. 2012;118:112–117. - PubMed
-
- The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement. Castagnola C, Nozza A, Corso A, Bernasconi C. https://haematologica.org/article/view/984. Haematologica. 1997;82:577. - PubMed
Publication types
LinkOut - more resources
Full Text Sources